SCHEMBL12237707

SCHEMBL12237707

Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.37
KMT2A Q03164 2/20 0.36
TP53 P04637 2/20 0.36
MAPT P10636 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CASP3 P42574 2/20 0.35
LSS P48449 1/20 0.35
MEN1 O00255 1/20 0.35
FFAR1 O14842 1/20 0.35
GLA P06280 1/20 0.35
KIT P10721 1/20 0.35
FLT4 P35916 1/20 0.35
KDR P35968 1/20 0.35
FLT3 P36888 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4491083 0.90 ROCK2 (0.37) ROCK2KMT2AMAPTMAOAMAOB
SCHEMBL4491081 0.90 ROCK2 (0.37) ROCK2KMT2AMAPTMAOAMAOB
SCHEMBL3157925 0.89 ROCK2 (0.43) ROCK2HDAC1LSSCYP3A4CYP2C19
SCHEMBL15425751 0.89 ROCK2 (0.37) ROCK2MAOAMAOBHDAC1LSS
SCHEMBL15408466 0.89 ROCK2 (0.37) ROCK2MAOAMAOBHDAC1LSS
SCHEMBL4487046 0.89 LSS (0.44) ROCK2MAPTLSS
SCHEMBL15408464 0.89 ROCK2 (0.37) ROCK2MAOAMAOBHDAC1LSS
SCHEMBL4504089 0.89 BACE1 (0.43) ROCK2TP53MAPTSMN1; SMN2MAOA
SCHEMBL3157931 0.89 ROCK2 (0.43) ROCK2HDAC1LSSCYP3A4CYP2C19
SCHEMBL4504092 0.89 BACE1 (0.43) ROCK2TP53MAPTSMN1; SMN2MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853420-B2 Compounds BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-10-07 US disclosed
US-20140018372-A1 CRYSTALLINE FORM OF A INDOLINONE DERIVATIVE AND ITS USE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-16 US disclosed
US-20110263565-A1 COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263565-A1 COMPOUNDS MKI67, CCNA1, CCNT1 ROCK2 2151/4885KMT2A 3158/4885TP53 117/4885
US-20140018372-A1 CRYSTALLINE FORM OF A INDOLINONE DERIVATIVE AND ITS USE PIR, IDO1, UACA ROCK2 2267/4885KMT2A 1999/4885TP53 1321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.